SCHEMBL29485

SCHEMBL29485

CCOC(=O)CC1(C)OOC(C)(C)CCC(C)(C)OO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.42
CTDSP1 Q9GZU7 1/20 0.41
KMT2A Q03164 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MGAM O43451 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
ALDH1A1 P00352 7/20 0.36
TRPA1 O75762 1/20 0.36
ALOX15 P16050 2/20 0.34
TSHR P16473 2/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
LMNA P02545 2/20 0.33
POLB P06746 1/20 0.33
CYP1A2 P05177 1/20 0.32
HSD17B10 Q99714 3/20 0.32
HPGD P15428 1/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1736191 0.89 GAA (0.48) GAACTDSP1KMT2AL3MBTL1MGAM
SCHEMBL7563295 0.84 KMT2A (0.45) GAACTDSP1KMT2AL3MBTL1MGAM
SCHEMBL9149563 0.83 CYP1A2 (0.38) GAACTDSP1KMT2AL3MBTL1MGAM
SCHEMBL9152148 0.81 TP53 (0.39) GAAMGAMSIMGAM2TSHR
SCHEMBL28459596 0.79 CTDSP1 (0.38) GAACTDSP1KMT2AL3MBTL1MGAM
SCHEMBL180341 0.76 CTDSP1 (0.47) GAACTDSP1KMT2AL3MBTL1MGAM
SCHEMBL10594774 0.73 CTDSP1 (0.48) GAACTDSP1KMT2AL3MBTL1MGAM
SCHEMBL597365 0.72 KMT2A (0.51) GAACTDSP1KMT2AL3MBTL1MGAM
SCHEMBL8146725 0.70 TSHR (0.45) GAACTDSP1KMT2AL3MBTL1MGAM
SCHEMBL13282718 0.70 CTDSP1 (0.56) GAACTDSP1KMT2AL3MBTL1MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260027750-A1 Continuous Extruder Process for Manufacturing Rheology-Modified Polyolefin for Cable Insulation Layer, and Related Products DOW GLOBAL TECHNOLOGIES LLC (US) 2026-01-29 US claimed
US-20250353938-A1 DYNAMICALLY CROSSLINKED POLYOLEFIN PRODUCED THROUGH A POST-REACTOR PROCESS WITH A DYNAMIC DISULFIDE CROSSLINKER BRASKEM AMERICA INC (US) 2025-11-20 US claimed
WO-2025235568-A1 ETHYLENE BASED CO/TERPOLYMERS CONTAINING A HIGH PURITY -S-S- BASED DYNAMIC CROSSLINKER TO PRODUCE AN IN-REACTOR DYNAMIC MATERIAL BRASKEM AMERICA, INC. (US) 2025-11-13 WO claimed
US-20250346695-A1 ETHYLENE BASED CO/TERPOLYMERS CONTAINING A HIGH PURITY -S-S- BASED DYNAMIC CROSSLINKER TO PRODUCE AN IN-REACTOR DYNAMIC MATERIAL BRASKEM AMERICA INC (US) 2025-11-13 US claimed
US-20250257190-A1 COMPOSITION COMPRISING AT LEAST ONE DIALKYL OR PEROXYKETAL PEROXIDE AND AT LEAST ONE UNSATURATED ORGANIC PEROXIDE ARKEMA FRANCE (FR) 2025-08-14 US claimed
US-20250243302-A1 FREE RADICAL ETHYLENE/TERPENE COPOLYMERS BRASKEM S.A. (BR) 2025-07-31 US claimed
WO-2025129179-A1 FREE RADICAL ETHYLENE/TERPENE COPOLYMERS BRASKEM S.A. (BR) 2025-06-19 WO claimed
EP-4486823-A1 OPEN CELL POLYMER FOAM COMPOSITION WITH TUNABLE TORTUOSITY AND METHOD OF MAKING THE SAME Braskem S.A. (BR) 2025-01-08 EP claimed
WO-2023161726-A1 OPEN CELL POLYMER FOAM COMPOSITION WITH TUNABLE TORTUOSITY AND METHOD OF MAKING THE SAME BRASKEM S.A. (BR) 2023-08-31 WO claimed
US-11613045-B2 Continuous extruder process for manufacturing rheology-modified polyolefin for cable insulation layer, and related products DOW GLOBAL TECHNOLOGIES LLC (US) 2023-03-28 US claimed
US-6197213-B1 SCORCH PROTECTION ACHIEVED FOR THERMOPLASTIC RESINS AND ELASTOMER DURING COMPOUNDING WHEN USING A PEROXIDE FREE RADICAL CATALYST BY ALSO USING IN ADDITION A COMBINATION OF A HYDROQUINONE AND A SULFUR ACCELERATOR; SYNERGISTIC ATOFINA CHEMICALS, INC. 2001-03-06 US claimed
US-5912304-A MIXING WITH HYDROQUINONE AND DITHIOCARBAMATE, THIURAM, THIAZOLE, OR SULFENAMIDE ACCELERATOR ELF ATOCHEM NORTH AMERICA, INC. (US) 1999-06-15 US claimed
EP-0504920-B1 Scorch retarding curing/crosslinking compositions ATOCHEM NORTH AMERICA ELF (US) 1998-07-08 EP claimed
EP-0504920-A2 Scorch retarding curing/crosslinking compositions ELF ATOCHEM NORTH AMERICA, INC. (US) 1992-09-23 EP claimed
US-20260075963-A1 TRIGGERABLE ENCAPSULANT MATERIAL FOR PHOTOVOLTAICS, PHOTOVOLTAIC MODULE, AND METHOD OF PRODUCING TRIGGERABLE ENCAPSULANT MATERIAL BRASKEM AMERICA INC (US) 2026-03-12 US disclosed
EP-4688891-A2 COMPOSITIONS AND METHODS FOR MAKING A REVERSIBILY-CROSSLINKED POLYMER Braskem America, Inc. (US) 2026-02-11 EP disclosed
US-20260027750-A1 Continuous Extruder Process for Manufacturing Rheology-Modified Polyolefin for Cable Insulation Layer, and Related Products DOW GLOBAL TECHNOLOGIES LLC (US) 2026-01-29 US disclosed
EP-0214361-A2 Scorch resistant, crosslinkable composition containing mixture of copper and metal dithiocarbamates ATOCHEM NORTH AMERICA, INC. (a Pennsylvania corp.) (US) 1987-03-18 EP disclosed
US-4632950-A Scorch resistant, crosslinkable composition containing mixture of copper and metal dithiocarbamates PENNWALT CORPORATION (US) 1986-12-30 US disclosed
EP-0129328-A2 Anionic surfactants OLIN CORPORATION (US) 1984-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260027750-A1 Continuous Extruder Process for Manufacturing Rheology-Modified Polyolefin for Cable Insulation Layer, and Related Products SEC16A, RBM17, IDE GAA 4088/4885CTDSP1 4106/4885KMT2A 4637/4885
US-20260075963-A1 TRIGGERABLE ENCAPSULANT MATERIAL FOR PHOTOVOLTAICS, PHOTOVOLTAIC MODULE, AND METHOD OF PRODUCING TRIGGERABLE ENCAPSULANT MATERIAL YWHAZ, RAD51, LBR GAA 4858/4885CTDSP1 1101/4885KMT2A 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.